Status:
WITHDRAWN
Behavioral Relaxation Approaches for Insomnia in Lung Cancer Patients
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Insomnia
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a randomized, 30-day research study that is exploring the effects of two simplified mindfulness interventions in lung cancer patients aimed to improve their sleep quality and anxiety regarding...
Detailed Description
The objective is to implement and examine the outcomes of a simplified relaxation intervention, Assisted Relaxation Therapy (ART), for lung cancer patients who experience insomnia symptoms and other s...
Eligibility Criteria
Inclusion
- 18 or older
- Diagnosed with Lung Cancer (In remission, Undergoing Immune Modulated Chemotherapy, Undergoing Platinum-based Chemotherapy
- Fluent in English
- Has Access to Smartphone
- Has internet connection at home
- More than 4 weeks post-surgery
Exclusion
- Inability to speak English or communicate verbally
- Medical or other factors that, in the opinion of the study research team, would interfere with their ability to participate in the intervention (such as inability to participate in the guided compassion training due to deafness)
Key Trial Info
Start Date :
September 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04318249
Start Date
September 30 2023
End Date
April 1 2027
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104